BVF INC/IL - ALPINE IMMUNE SCIENCES INC ownership

ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 59 filers reported holding ALPINE IMMUNE SCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
BVF INC/IL ownership history of ALPINE IMMUNE SCIENCES INC
ValueSharesWeighting
Q1 2023$6,626,377
-20.6%
858,339
-24.4%
0.24%
-31.2%
Q4 2022$8,349,159
+2.1%
1,135,9400.0%0.35%
+4.1%
Q3 2022$8,179,000
-24.6%
1,135,940
-10.9%
0.34%
-35.5%
Q2 2022$10,852,000
-23.9%
1,275,240
-19.8%
0.52%
-8.1%
Q1 2022$14,258,000
-35.2%
1,589,4950.0%0.57%
-28.7%
Q4 2021$22,015,000
+29.8%
1,589,4950.0%0.80%
+20.7%
Q3 2021$16,960,000
+417.5%
1,589,495
+39.7%
0.66%
+117.0%
Q1 2020$3,277,000
-25.0%
1,137,7640.0%0.30%
-7.9%
Q4 2019$4,369,000
-2.0%
1,137,7640.0%0.33%
-29.4%
Q3 2019$4,460,000
-8.0%
1,137,764
-1.2%
0.47%
-11.5%
Q2 2019$4,849,000
-41.2%
1,151,717
-4.2%
0.53%
-42.6%
Q1 2019$8,244,000
+248.4%
1,201,717
+86.9%
0.92%
+198.7%
Q4 2018$2,366,000
-41.9%
643,0590.0%0.31%
-13.7%
Q3 2018$4,071,000
-16.4%
643,0590.0%0.36%
-24.6%
Q2 2018$4,868,000
-10.0%
643,059
-4.8%
0.48%
-13.3%
Q1 2018$5,406,000
-28.6%
675,7590.0%0.55%
-39.9%
Q4 2017$7,569,000
-3.4%
675,7590.0%0.91%
-8.4%
Q3 2017$7,839,000675,7591.00%
Other shareholders
ALPINE IMMUNE SCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,571,450$17,640,0004.25%
BVF INC/IL 1,201,717$8,244,0000.92%
Orbimed Advisors 3,670,955$25,183,0000.39%
TIGER MANAGEMENT L.L.C. 137,728$945,0000.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 475,450$3,262,0000.12%
Hikari Power Ltd 122,972$844,0000.09%
ALPINE WOODS CAPITAL INVESTORS, LLC 15,000$103,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 35,750$245,0000.00%
DRW Securities, LLC 10,000$69,0000.00%
VICTORY CAPITAL MANAGEMENT INC 134,542$923,0000.00%
View complete list of ALPINE IMMUNE SCIENCES INC shareholders